These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26634312)

  • 1. Vaccines and Kawasaki disease.
    Esposito S; Bianchini S; Dellepiane RM; Principi N
    Expert Rev Vaccines; 2016; 15(3):417-24. PubMed ID: 26634312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007.
    Hua W; Izurieta HS; Slade B; Belay ED; Haber P; Tiernan R; Woo EJ; Iskander J; Braun MM; Ball R
    Pediatr Infect Dis J; 2009 Nov; 28(11):943-7. PubMed ID: 19755926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM; Shulman ST
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kawasaki syndrome, still a mystery].
    Winterberg Dh
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):436-9. PubMed ID: 17972613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006.
    Abrams JY; Weintraub ES; Baggs JM; McCarthy NL; Schonberger LB; Lee GM; Klein NP; Belongia EA; Jackson ML; Naleway AL; Nordin JD; Hambidge SJ; Belay ED
    Vaccine; 2015 Jan; 33(2):382-7. PubMed ID: 25444786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunologic aspects of Kawasaki disease.
    Leung DY
    Immunodefic Rev; 1989; 1(3):261-71. PubMed ID: 2698643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease: insights into pathogenesis and approaches to treatment.
    Shulman ST; Rowley AH
    Nat Rev Rheumatol; 2015 Aug; 11(8):475-82. PubMed ID: 25907703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki disease and scald injuries: a possible association.
    Wong D; Nutting A; Yeung RS; McCrindle BW
    Can J Cardiol; 2004 Sep; 20(11):1147-9. PubMed ID: 15457311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease and immunisation: A systematic review.
    Phuong LK; Bonetto C; Buttery J; Pernus YB; Chandler R; Felicetti P; Goldenthal KL; Kucuku M; Monaco G; Pahud B; Shulman ST; Top KA; Trotta F; Ulloa-Gutierrez R; Varricchio F; de Ferranti S; Newburger JW; Dahdah N; Singh S; Bonhoeffer J; Burgner D;
    Vaccine; 2017 Mar; 35(14):1770-1779. PubMed ID: 28259442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: A case report.
    Yin S; Liubao P; Chongqing T; Xiaomin W
    Hum Vaccin Immunother; 2015; 11(11):2740-3. PubMed ID: 26158590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease.
    Burns JC; Touma R; Song Y; Padilla RL; Tremoulet AH; Sidney J; Sette A; Franco A
    Autoimmunity; 2015 May; 48(3):181-8. PubMed ID: 25822882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kawasaki disease (mucocutaneous lymph node syndrome in children)].
    Zernov NG; Kostikov MV; Fedorov AM
    Pediatriia; 1983 Apr; (4):71-3. PubMed ID: 6348691
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
    Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki shock syndrome complicating a recurrence of Kawasaki disease.
    Tissandier C; Lang M; Lusson JR; Bœuf B; Merlin E; Dauphin C
    Pediatrics; 2014 Dec; 134(6):e1695-9. PubMed ID: 25384485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics.
    Horinouchi T; Nozu K; Hamahira K; Inaguma Y; Abe J; Nakajima H; Kugo M; Iijima K
    BMC Pediatr; 2015 Nov; 15():177. PubMed ID: 26561332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):501.e1-11; quiz 511-2. PubMed ID: 24034379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Kawasaki disease in a patient with PFAPA.
    Ninomiya T; Takada H; Nagatomo Y; Nanishi E; Nagata H; Yamamura K; Doi T; Ikeda K; Hara T
    Pediatr Int; 2013 Dec; 55(6):801-2. PubMed ID: 24330294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease: an overview.
    Pinna GS; Kafetzis DA; Tselkas OI; Skevaki CL
    Curr Opin Infect Dis; 2008 Jun; 21(3):263-70. PubMed ID: 18448971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of Kawasaki disease in burn children].
    Feng J; Li WR; Wang W
    Zhonghua Shao Shang Za Zhi; 2011 Aug; 27(4):299-301. PubMed ID: 22097304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.